Mark Israel, a pediatric oncologist and translational scientist, was appointed national executive director of the Israel Cancer Research Fund, a nonprofit organization dedicated solely to funding cancer research in Israel.
International Association for the Study of Lung Cancer becomes member of registry of real-world data
The International Association for the Study of Lung Cancer has become a member of the Lung Cancer Patient Registry.
Elizabeth Barrett was appointed CEO Novartis Oncology and a member of the executive committee of Novartis.
Howard “Skip” Burris III was elected president of the American Society of Clinical Oncology for the term beginning in June 2019.xxx:moreBurris is president of clinical operations and chief medical officer for Sarah Cannon, the cancer institute of HCA Healthcare. He is an associate of Tennessee Oncology, PLLC.B
Howard Hochster assumed the role of associate director for clinical research and chief of gastrointestinal medical oncology at Rutgers Cancer Institute, as well as director of cancer clinical research for oncology services at RWJBarnabas Health.
Timothy Whitten was named president of Taiho Oncology Inc., a subsidiary of Taiho Pharmaceutical Co. Ltd.
Purdue University's Center for Cancer Research received a $10 million matching-funds gift from the Indianapolis-based Walther Cancer Foundation to advance its research in drug discovery, treatments and potential cures.
METAvivor Research and Support Inc., a non-profit organization dedicated to funding research for stage IV metastatic breast cancer, announced twelve grant awards totaling $1,650,000.
The Jackson Laboratory launched the Tallwood Canine Cancer Research Initiative, which will create a biobank of dog tumors that the nonprofit biomedical research institution plans to use and share with researchers around the world to provide new insights into cures for cancer in humans and dogs.
DONALD BROWN donated $30 million to Indiana University School of Medicine to establish the Brown Center for Immunotherapy. The Brown Center for Immunotherapy will initially focus on multiple myeloma and triple negative breast cancer, two diseases for which the School of Medicine and its clinical partner Indiana University Health have a strong foundation of talent,... […]
